A Psychedelic Drug Revolution is underway to address the Mental Health Crisis. As with all revolutions, we are seeing a rapid shift in attitudes.
Psychedelics
Increasing Interest in Psychedelics for Medical Purposes
Investors are always looking for hot new markets to invest in.
New York Bill Would Create State-Sponsored Psychedelics Research Institute
A New York lawmaker introduced a bill on Tuesday that would require the state to establish an institute to research the therapeutic potential of psychedelics.
Feds Should Work With—Not Against—States That Legalize Psychedelics, Government Health Official Says
Oregon’s move to legalize psilocybin mushrooms for therapeutic use should signal to the federal government that it needs to engage with jurisdictions that pursue such reforms and aid in the development of regulatory frameworks, a federal health official says.
Psychedelic Drug Stocks: A BIG Healthcare Footprint At A SMALL Price
The psychedelic drug industry already has a large footprint in healthcare. And it is growing in literally every direction.
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
California Senate Approves Bill To Legalize Possession Of Psychedelics Like Psilocybin And LSD
A bill to legalize possession of psychedelics in California was approved by the California Senate on Tuesday.
Bill to Legalize Psilocybin Therapy Introduced in Maine
A bill filed in Maine would legalize psilocybin mushroom therapy without a medical diagnosis, and allow adults 21-and-older to legally buy the psychedelic and use it under the supervision of a certified psilocybin service practitioner, according to the Dales Report.
This is why psilocybin may be able to help millions
It may only be a matter of time before psychedelics become a go-to treatment for millions suffering with some sort of mental illness.
Mental Health Care May Never be the Same With Biotech
There’s been a substantial proof psychedelics can help with issues such as depression, anxiety, addiction, obsessive compulsive disorder, and obesity.
Texas Closer to Passing Bill That Studies Medicinal Psychoactive Drugs
The bill passed 6-0 and has garnered bipartisan support.
Health Official Touts Psilocybin's’ Therapeutic Benefits
A top U.S. health official on Wednesday touted the therapeutic potential of psychedelics like psilocybin and MDMA.
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
Mydecine receives regulatory approval to expand its psilocybin mushroom cultivation operations.
Shroom boom?
Research is proving the potential psychedelics hold when it comes to healing mental health. Now, investors are looking to cash in.
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
NASDAQ-listed Enveric Biosciences is merging with private psychedelics company, Magic Med Industries.